Latista™ Field helps Eli Lilly successfully implement commissioning and qualification program
Eli Lilly & Co., the tenth-largest pharmaceutical manufacturer in the world, is constantly building facilities. Spending $1B annually on construction, Lilly is concerned about quality, cost, risk management and time to market on all of its projects.
For the construction of IE42, a 158 square foot manufacturing plant in Kinsale, Ireland, Lilly implemented Latista™ Field as a central part of the project’s technology solution and unified Lilly’s CQM process for all 163 end users on the project in Ireland and at Lilly’s U.S. headquarters. Lilly was able to finish construction and occupy the site in April 2010, two months earlier than anticipated.